Annular Epidermolytic Ichthyosis (AEI)

Annular epidermolytic ichthyosis (AEI) is a very rare, inherited skin condition. “Annular” means ring-shaped, “epidermolytic” means the top layer of skin is fragile and breaks down easily, and “ichthyosis” means dry, thick, scaly skin. Babies may have redness and blisters at birth that improve. Later in childhood, people develop repeating flares of red, scaly, ring-like patches that slowly move or change shape. Many also have thick skin on the palms and soles (palmoplantar keratoderma). Under the microscope, the skin shows a pattern called “epidermolytic hyperkeratosis.” AEI is a clinical variant of epidermolytic ichthyosis caused by changes (mutations) in the skin proteins keratin 1 (KRT1) or keratin 10 (KRT10). NCBI+3GARD Information Center+3Orpha.net+3

Annular epidermolytic ichthyosis (AEI) is a very rare form (variant) of epidermolytic ichthyosis (EI). EI is a genetic skin condition in which the outer skin layer (epidermis) is fragile at birth, so babies can have redness, blisters, and raw areas. As the child grows, the skin becomes thick and scaly. AEI follows that same pattern at birth, but later in childhood or adolescence it shows ring-shaped (annular), wavy (polycyclic), scaly red patches that come and go in “flares.” These patches usually appear on the trunk and upper arms and thighs and may merge into larger patterns. Histology shows the typical epidermolytic hyperkeratosis pattern under the microscope. JAAD+3PMC+3PMC+3

AEI belongs to the family of keratinopathic ichthyoses—a group of inherited skin disorders caused by changes (variants) in keratin genes that give strength to skin cells. Most people with AEI have a pathogenic variant in KRT1 or KRT10, the genes for keratin 1 and keratin 10. These variants weaken the “scaffolding” inside skin cells (keratinocytes), which leads to blistering early in life and later scaling and thickening. Inheritance is usually autosomal dominant (one changed copy is enough), though rare recessive forms exist for EI in general. Medical Journals+3PMC+3DermNet®+3

---

Other names

AEI has been described in the literature by several names. Doctors might use:

• Annular epidermolytic ichthyosis

• Annular variant of epidermolytic ichthyosis

• Annular form of bullous congenital ichthyosiform erythroderma (BCIE)

• Cyclic (migratory) erythematous hyperkeratotic plaques in EI (descriptive phrase sometimes used in reports)

All of these refer to the same clinical pattern: the ring-like, migrating, scaly plaques that occur after the early EI phase improves. PMC+1

---

Types

Doctors group keratin-related ichthyoses into types based on the main gene and the depth of skin fragility. Classic epidermolytic ichthyosis (EI) is due to KRT1 or KRT10 variants and shows blistering at birth with later thick scaling. Annular epidermolytic ichthyosis is a clinical variant of classic EI, defined by its recurrent ring-shaped plaques later in life. Two related conditions are superficial epidermolytic ichthyosis (SEI, also called ichthyosis bullosa of Siemens) due to KRT2 (more superficial blistering), and epidermolytic palmoplantar keratoderma (EPPK) (KRT9, mainly palms/soles). AEI is not a separate gene category; it is a phenotype within KRT1/KRT10-related EI. DermNet®+3Orpha.net+3Orpha.net+3

Within EI due to KRT1, palmoplantar keratoderma (thickening of palms/soles) is more common, while KRT10 cases often spare the palms and soles. AEI can occur with either KRT1 or KRT10 variants and often shows improvement after infancy followed by intermittent annular flares, sometimes triggered by heat, friction, or infections. DermNet®+2PMC+2

AEI is a lifelong, inherited skin condition. Babies are usually born with red, fragile, blistering skin that heals but later becomes thick and scaly. During childhood, teenagers, or sometimes adulthood, people develop ring-shaped, migrating patches of red, scaly, sometimes itchy skin that come and go. The cause is a change in a keratin gene (KRT1 or KRT10) that weakens the internal structure of skin cells. The condition is not contagious. Treatment focuses on skin care, reducing triggers, and sometimes using prescribed creams, keratolytics, retinoids, or other therapies guided by a dermatologist. PMC+2PMC+2

---

Causes

Important note: In AEI, the root cause is genetic (a pathogenic variant in KRT1 or KRT10). The items below explain both the primary cause and factors that trigger or worsen flares. Triggers do not change the genes, but they can make the rash worse or bring on an episode.

1. KRT1 pathogenic variants – weaken keratin filaments; often associated with thick palms/soles. DermNet®

2. KRT10 pathogenic variants – similar mechanism; palms/soles often less affected. DermNet®

3. Autosomal-dominant inheritance – one affected parent can pass it on; many cases are familial. Medical Journals

4. De novo (new) variants – the child is the first in the family to have the variant. Lippincott Journals

5. Keratin “hotspot” changes – variants in conserved regions of keratin proteins are especially disruptive. ScienceDirect

6. Heat – warmth and sweating can trigger or worsen annular flares. geneskin.org

7. Friction (rubbing) – mechanical stress makes fragile skin blister or scale more. geneskin.org

8. Minor trauma – bumps/scratches can start new plaques or erosions. geneskin.org

9. Skin infections – bacterial or fungal infections can worsen inflammation and scaling. National Organization for Rare Disorders

10. Dry air/low humidity – increases scaling and cracking. DermNet®

11. Irritants (harsh soaps, detergents) – strip oils and aggravate the barrier. DermNet®

12. Occlusion/sweating in skin folds – favors maceration and flare-ups. PMC

13. Sun exposure in some patients – may sting or trigger irritation (variable). DermNet®

14. Fever/illness – systemic stress can precede a flare. PMC

15. Certain topical medicines – strong steroids or irritant keratolytics can sometimes over-thin or irritate skin if misused. (General ichthyosis care caution.) DermNet®

16. Allergic/contact dermatitis – added inflammation worsens plaques. DermNet®

17. Poor emollient use – skipping moisturizers dries the barrier and increases scaling. DermNet®

18. Psychological stress – may worsen itch–scratch cycles (nonspecific but relevant to chronic skin disease). National Organization for Rare Disorders

19. Secondary malodor or crusting – promotes social avoidance and altered care, indirectly worsening disease. National Organization for Rare Disorders

20. Genetic variability (different variants, same genes) – explains why severity and features (like palm involvement) differ between people. JAMA Network

---

Common symptoms and signs

1. At birth: redness and blistering (skin fragility). Orpha.net

2. Superficial erosions that heal but recur with friction. geneskin.org

3. Thickened, scaly skin (hyperkeratosis) developing after infancy. Orpha.net

4. Annular (ring-shaped), polycyclic plaques that migrate or change shape over time. PMC

5. Recurrent flares separated by quieter periods (cyclic course). PMC

6. Itching or burning during active plaques. PMC

7. Scaling that peels at edges of plaques. PMC

8. Palmoplantar thickening in many KRT1 cases. DermNet®

9. Flexural (body fold) involvement with maceration in some patients. geneskin.org

10. Post-inflammatory color change after plaques settle. PMC

11. Cracking and fissures that can be painful. National Organization for Rare Disorders

12. Secondary infections (ooze, crust, odor) during flares. National Organization for Rare Disorders

13. Heat/sweat intolerance (flares in summer or after exercise). geneskin.org

14. Koebner phenomenon-like responses (new lesions along scratch lines). PMC

15. Psychosocial impact (embarrassment, discomfort, sleep disturbance). National Organization for Rare Disorders

---

Diagnostic tests

AEI is mainly a clinical diagnosis supported by skin biopsy (showing epidermolytic hyperkeratosis) and genetic testing (showing a pathogenic variant in KRT1 or KRT10). Other tests help map severity, rule out look-alikes, and guide care.

A) Physical examination (bedside assessment)

1. Full-body skin exam – to see ring-shaped, migrating, scaly plaques on trunk/proximal limbs and to check for residual blistering or erosions. Pattern recognition is key. PMC

2. Palm/sole evaluation – look for palmoplantar keratoderma that favors KRT1 variants. Helps narrow the gene target for testing. DermNet®

3. Assessment of triggers – note heat, friction, sweating, and minor trauma that precede flares; advise avoidance as part of care. geneskin.org

4. Infection screen – check for crusts, malodor, or oozing; treat secondary infection to reduce inflammation and odor. National Organization for Rare Disorders

B) “Manual clinical tests and simple tools

5. Nikolsky-like gentle shear test – very light rubbing can sometimes show epidermal fragility in active areas; used cautiously and rarely, as it can injure skin. Orpha.net

6. Dermoscopy – handheld scope view may show white/yellow scales, rim-like edges, and background erythema; supports clinical impression though not diagnostic alone. DermNet®

7. Wood’s lamp – mostly to check for Pseudomonas (green) or erythrasma (coral-red) if odor or maceration suggests secondary infection. DermNet®

8. High-resolution clinical photography – tracks lesion migration over weeks to document the “annular, polycyclic” pattern for diagnosis and response to treatment. PMC

C) Laboratory and pathology tests

9. Skin biopsy (H&E) – shows epidermolytic hyperkeratosis: thick stratum corneum, vacuolization and clumping in the upper spinous and granular layers, and keratin filament disruption. This is the classic histology. DermNet®

10. Electron microscopy (if available) – reveals collapsed keratin filaments and cytolysis in upper epidermis; used in difficult cases or research settings. Medical Journals

11. Targeted genetic testing of KRT1/KRT10 – confirms the exact variant; the most definitive test for EI/AEI. NCBI

12. Broader multigene panel for ichthyosis – useful when the clinical picture overlaps with other keratinopathies (e.g., KRT2/SEI) or when initial testing is negative. JAMA Network

13. Family testing and segregation analysis – clarifies inheritance, identifies affected relatives, and supports variant interpretation. Medical Journals

14. Bacterial/fungal cultures from crusted or oozing areas – to guide antibiotics/antifungals if secondary infection is suspected. National Organization for Rare Disorders

15. Routine labs (baseline safety) – while not diagnostic, baseline liver/lipid tests are helpful before systemic retinoids or other systemic therapies when those are considered. National Organization for Rare Disorders

D) Electrodiagnostic tests

16. Electrodiagnostic studies (EMG/nerve tests) – not used to diagnose AEI. Very rarely considered to exclude unrelated neuropathic itch or pain if symptoms are atypical; they do not show specific abnormalities in AEI. (Included here to clarify they are generally unnecessary.) UpToDate

17. ECG/other electrophysiology – not part of AEI work-up; only used if a medication being considered has cardiac risk or if there is another health problem. UpToDate

E) Imaging and advanced optical tests

18. Reflectance confocal microscopy (RCM) – noninvasive imaging that can visualize superficial epidermal changes; sometimes used in research or specialized clinics to study keratinization patterns. JAMA Network

19. Optical coherence tomography (OCT) of skin – another noninvasive tool that can show thickened stratum corneum; supportive, not diagnostic by itself. JAMA Network

20. Teledermatology/remote imaging review – high-quality images assessed by an ichthyosis expert can speed recognition of the annular EI pattern in under-served areas. This complements, but does not replace, biopsy/genetics when needed.

Non-Pharmacological Treatments (Therapies & Other Measures)

Each item includes a brief description, purpose, and mechanism in simple terms.

1. Daily lukewarm soaking and gentle cleansing
   A short daily soak softens thick scale. Use a mild, fragrance-free cleanser and pat dry. Purpose: reduce scale without trauma. Mechanism: water hydrates the outer layer (stratum corneum), making scale easier to lift. akademiska.se

2. Thick emollients right after bathing (“soak and seal”)
   Apply petrolatum, glycerin, or ceramide-rich creams while skin is damp to lock in water. Purpose: reduce dryness and cracking. Mechanism: occlusion and lipid replacement restore the barrier. akademiska.se+1

3. Humidifier use in dry environments
   Keeping indoor air moist reduces skin water loss. Purpose: comfort and less scaling. Mechanism: higher ambient humidity lowers transepidermal water loss. akademiska.se

4. Controlled, cautious keratolysis by physical methods
   For thick palms/soles, gentle mechanical debridement (e.g., pumice) after soaking. Purpose: smoother skin and fewer painful fissures. Mechanism: reduces excess keratin buildup. (Avoid aggressive scraping.) akademiska.se

5. Wet-wrap therapy during flares
   Briefly covering medicated moisturizers with damp then dry layers can soften plaques and calm irritation. Purpose: speed relief. Mechanism: occlusion enhances hydration and penetration of topicals. akademiska.se

6. Friction and heat avoidance
   Wear soft fabrics, avoid rough seams, and manage heat/sweating, which can trigger flares and maceration. Purpose: fewer erosions and flares. Mechanism: less mechanical and heat stress on fragile epidermis. PubMed

7. Targeted antiseptic hygiene when prone to infections
   Short courses of bleach baths or antiseptic washes may be advised to reduce bacterial load if recurrent infections occur. Purpose: prevent superinfection. Mechanism: lowers colonization of pathogens on compromised skin. akademiska.se

8. Nail and fissure care
   Keep nails trimmed; protect cracks with petrolatum and occlusive bandages. Purpose: reduce trauma and pain. Mechanism: supports barrier repair. akademiska.se

9. Footwear and insole optimization
   Cushioned, breathable shoes reduce pressure on plantar keratoderma. Purpose: less pain, fewer fissures. Mechanism: pressure distribution and sweat control. akademiska.se

10. Eye and ear monitoring in infancy (as needed)
    Some ichthyosis subtypes risk eye irritation or ear canal scale; periodic checks help, especially in babies. Purpose: early problem detection. Mechanism: prevents buildup and complications. akademiska.se

11. Psychological support and peer groups
    Visible skin disease can affect mood and social life; counseling helps coping. Purpose: improve quality of life. Mechanism: skills and support reduce stress-related flare behaviors. akademiska.se

12. Sun protection
    Use shade, clothing, and sunscreen suitable for sensitive skin. Purpose: prevent burns on fragile skin. Mechanism: reduces UV injury to compromised epidermis. akademiska.se

13. Allergen/irritant minimization
    Fragrance-free, dye-free products lower irritation risk. Purpose: fewer stings and flares. Mechanism: avoids contact irritants on leaky barrier. akademiska.se

14. Gentle temperature and sweat management
    Fans, cool showers, and breathable clothing lower sweating that can sting and macerate skin. Purpose: comfort. Mechanism: reduces moisture-related breakdown. akademiska.se

15. Structured home-care routine (checklists)
    Daily plans for bathing, moisturizing, and flare-care improve adherence and outcomes. Purpose: consistency. Mechanism: habit building for barrier repair. akademiska.se

16. Education on infant safety with topicals
    In babies, some acids and urea can be risky; families need clear instructions to avoid toxicity. Purpose: safe care. Mechanism: prevents percutaneous absorption harms. HUSC

17. Genetic counseling for families
    Explains inheritance, testing, and family planning options. Purpose: informed decisions. Mechanism: clarifies autosomal-dominant transmission and de novo variants. Orpha.net

18. School and workplace accommodations
    Allow time for skin care and temperature control. Purpose: maintain participation. Mechanism: reduces triggers during the day. akademiska.se

19. Infection vigilance and early treatment
    Know signs of impetigo/cellulitis on cracked skin and seek prompt care. Purpose: prevent complications. Mechanism: quick antimicrobial therapy when needed. akademiska.se

20. Bone health monitoring if systemic retinoids are used
    For long-term retinoid therapy, growth checks (children) and periodic DEXA (adults) are recommended. Purpose: prevent retinoid-related bone effects. Mechanism: surveillance catches changes early. PMC

---

Drug Treatments

Important: Medicines should be prescribed and adjusted only by your clinician, who will tailor choices, doses, and monitoring to age, severity, other illnesses, and pregnancy plans.

1. Acitretin (oral retinoid)
   Class: systemic retinoid. Typical dose: ~0.2–1 mg/kg/day (lowest effective dose). Timing: daily, long-term with breaks. Purpose: thins heavy scale, improves plaques and PPK. Mechanism: normalizes keratinization and reduces hyperkeratosis. Side effects: dry lips/eyes, liver enzyme and lipid changes, bone effects with long use; strict pregnancy avoidance and contraception required. Monitoring: LFTs, fasting lipids, bone monitoring if prolonged. PMC

2. Isotretinoin (oral)
   Class: systemic retinoid. Dose: often 0.5–1 mg/kg/day; use minimal effective. Purpose: alternative to acitretin for scaling control. Mechanism: reduces epidermal thickness and scaling. Side effects/monitoring: similar to acitretin; teratogenic. PMC

3. Topical urea (5–40%)
   Class: keratolytic/humectant. Use: 1–2×/day to thick areas; avoid high-strength in infants. Purpose: soften and hydrate scale. Mechanism: breaks down keratin and draws water in. Side effects: sting/irritation; avoid in neonates except very limited areas. HUSC

4. Topical lactic acid/α-hydroxy acids (5–12%)
   Class: keratolytics. Use: once daily to thick plaques in older children/adults. Purpose: smooth scale. Mechanism: loosens corneocyte bonds. Caution: do not use in children <2 years; irritation possible. ResearchGate

5. Topical salicylic acid (≤6% to limited adult areas)
   Class: keratolytic. Use: spot-treat stubborn plaques; avoid widespread use and avoid in infants/young children due to toxicity risk. Purpose: scale reduction. Mechanism: dissolves intercellular cement. Side effects: salicylate toxicity if overused; irritation. HUSC

6. Propylene glycol (20–70% under occlusion, clinician-directed)
   Class: keratolytic/humectant. Use: intermittent courses. Purpose: soften plaques. Mechanism: hydrates and breaks down keratin. Side effects: irritation. Dermatology Times

7. Ceramide-containing moisturizers
   Class: barrier-repair topicals. Use: 1–2×/day routine. Purpose: restore missing skin lipids. Mechanism: replaces ceramides that help seal the barrier. Side effects: rare irritation; choose fragrance-free. DermNet®

8. Topical tazarotene (0.05–0.1%)
   Class: topical retinoid. Use: thin layer nightly to plaques as tolerated. Purpose: smooth hyperkeratosis. Mechanism: modulates keratinocyte differentiation. Side effects: irritation, photosensitivity; avoid in pregnancy. akademiska.se

9. Topical calcipotriol (calcipotriene)
   Class: vitamin D analog. Use: short-term courses up to ~100 g/week. Purpose: adjunct to reduce scaling. Mechanism: normalizes epidermal turnover. Side effects: irritation; follow clinician guidance. ResearchGate

10. Topical corticosteroids (low–mid potency, brief use on inflamed plaques)
    Class: anti-inflammatory. Use: short bursts during flares. Purpose: reduce redness and itch. Mechanism: suppresses local inflammation. Side effects: skin thinning with overuse; avoid chronic continuous use. akademiska.se

11. Topical antibiotics (for secondary infection)
    Class: antimicrobial. Use: short courses when impetiginized. Purpose: treat local infection. Mechanism: kills bacteria on broken skin. Side effects: resistance/irritation; not for routine prophylaxis. akademiska.se

12. Oral antibiotics (when needed for cellulitis)
    Class: antimicrobial. Use: time-limited per culture and clinician judgment. Purpose: treat spreading infection through fissures. Mechanism: systemic bacterial killing. Side effects: drug-specific; use only when infected. akademiska.se

13. Oral antihistamines (sedating at night if itchy)
    Class: H1 blockers. Use: bedtime for sleep relief. Purpose: reduce itch/scratch cycle. Mechanism: central sedation and antihistamine effect. Side effects: drowsiness. akademiska.se

14. Topical anesthetics for painful fissures (short term, small areas)
    Class: local anesthetic creams. Use: sparingly to cracks. Purpose: pain relief to allow walking/hand use. Mechanism: blocks nerve signaling. Side effects: irritation; avoid large areas. akademiska.se

15. Keratin-softening combinations (e.g., urea + lactic acid under clinician plan)
    Class: combo keratolytics. Use: step-wise escalation in adults. Purpose: stronger scale control. Mechanism: additive keratin breakdown and hydration. Safety: observe age restrictions. ResearchGate

16. Barrier “super-emollients” (petrolatum, lanolin-free options)
    Class: occlusives. Use: thick nighttime layer. Purpose: reduce TEWL, help healing. Mechanism: physical barrier seal. Side effects: folliculitis if very occlusive; patch test if sensitive. akademiska.se

17. Antiseptic washes (chlorhexidine, clinician-advised) during infection-prone periods
    Class: antiseptic. Use: limited days. Purpose: reduce bacterial load. Mechanism: membrane disruption of microbes. Caution: irritation; avoid eyes/ears. akademiska.se

18. Emollient “wet-wrap” with diluted corticosteroid for severe flares (clinician-guided)
    Class: combo emollient/anti-inflammatory. Use: short course. Purpose: quick calming of inflamed plaques. Mechanism: occlusion + anti-inflammation. Side effects: as above; supervised. akademiska.se

19. Pain control for fissures (paracetamol/acetaminophen as advised)
    Class: analgesic. Use: short term. Purpose: function and mobility. Mechanism: central pain modulation. Safety: dose per label; avoid NSAIDs if contraindicated. akademiska.se

20. Vitamin D supplementation when deficient; compare with retinoids in some studies
    Class: nutritional hormone. Use: correct deficiency; specialist may trial as adjunct. Purpose: potential symptom improvement and bone health. Mechanism: epidermal differentiation and systemic bone effects. Evidence: deficiency is common in ichthyoses; small studies and case series suggest benefit, but larger trials are needed. Wiley Online Library+3PMC+3BioMed Central+3

---

Dietary / Molecular Supplements

Note: Supplements are adjuncts, not cures. Evidence varies and is often indirect or limited for AEI. Discuss with your clinician.

1. Omega-3 fatty acids (fish oil/EPA-DHA)
   May modestly calm skin inflammation in some dermatoses; evidence in ichthyosis is limited but biologically plausible. Dose ranges vary (e.g., 1–3 g/day EPA+DHA in adults) under medical advice. Function: anti-inflammatory lipid mediator balance. Mechanism: shifts eicosanoid profile away from pro-inflammatory ω-6 pathways. PMC+1

2. Vitamin D (treat deficiency)
   If labs show low 25-OH-D, supplement per clinician (common adult repletion: 800–2000 IU/day, or higher short-term protocols). Function: supports epidermal differentiation and bone health; may improve symptoms in some patients. Mechanism: nuclear receptor effects in keratinocytes. PMC+2BioMed Central+2

3. Oral plant ceramides (rice/wheat/milk-derived)
   Clinical studies suggest improved skin hydration and barrier function with daily doses around 40–600 mg depending on product. Function: barrier lipid replenishment from within. Mechanism: ceramide/glucosylceramide assimilation reduces TEWL. MDPI+3PMC+3PubMed+3

4. Glycerol (glycerin) oral hydration support (mainly topical is preferred)
   Topically is first-line; oral forms are not standard and can cause GI upset—discuss with clinician. Function: humectant to attract water. Mechanism: improves water content in stratum corneum. akademiska.se

5. Evening primrose oil / γ-linolenic acid (GLA)
   Evidence is mixed; some barrier and itch benefits are reported in other skin diseases. Adult doses vary (e.g., 1–3 g/day oils). Function: lipid support. Mechanism: influences eicosanoids and barrier lipids. ScienceDirect

6. Multinutrient support if dietary gaps exist
   Balanced multivitamins/minerals may help general health; specific benefit for AEI is unproven. Function: corrects deficiencies. Mechanism: supplies cofactors for skin turnover. akademiska.se

7. Probiotics (experimental adjunct)
   Data in ichthyosis are minimal; any benefit would be indirect via immune modulation. Function: gut-skin axis support. Mechanism: alters cytokine milieu. (Use strain-specific products with clinician guidance.) ScienceDirect

8. Antioxidant-rich diet (berries/greens) rather than pills
   Whole-food antioxidants support overall skin health; supplement pills lack ichthyosis-specific proof. Function: reduce oxidative stress. Mechanism: scavenging reactive species. ScienceDirect

9. Adequate protein and essential fatty acids
   Dietary EFAs are required for normal barrier lipids; deficiency can worsen scaling. Function: structural lipid supply. Mechanism: provides substrates for ceramides/acyl-ceramides. First Skin Foundation

10. Hydration strategy (water intake matched to needs)
    Proper hydration supports skin turgor; avoid extreme over-hydration. Function: systemic support. Mechanism: maintains internal water balance. akademiska.se

---

Immunity-booster / Regenerative / Stem-cell Drugs

There are no approved immune-booster, regenerative, or stem-cell drugs for AEI. Below are research-oriented or concept-level approaches often asked about; they should not be used outside clinical trials or specialist care.

1. Topical gene therapy concepts (keratin correction)
   Experimental strategies aim to replace or silence mutant keratin genes; none are approved for AEI yet. Function: correct root cause. Mechanism: gene replacement/editing in keratinocytes (conceptual). SpringerLink

2. mRNA or ASO approaches (allele-specific silencing)
   Designed to reduce the harmful mutant keratin while keeping normal keratin. Function: decrease toxic protein. Mechanism: post-transcriptional silencing. (Research stage.) SpringerLink

3. Ex vivo corrected keratinocyte grafting (by analogy to other genetic skin diseases)
   Successful in other disorders (e.g., epidermolysis bullosa) suggests a possible future path, but not established in AEI. Function: replace diseased epidermis. Mechanism: transplant corrected skin sheets. SpringerLink

4. Retinoid-sparring biologics (theoretical)
   Biologics that reduce inflammation could, in theory, ease flares, but there is no AEI-specific evidence. Function: reduce inflammation burden. Mechanism: cytokine blockade (hypothesis only). SpringerLink

5. Topical recombinant lipids (advanced barrier therapy)
   Designer ceramides/omega-fatty acids may better mimic natural skin lipids; these are enhanced moisturizers, not cures. Function: barrier rebuilding. Mechanism: restores lipid lamellae. DermNet®

6. Vitamin D as a “regenerative” adjunct when deficient
   Correcting low vitamin D can improve skin differentiation and bone health; promising small studies exist but it is not a cure. Function: normalize keratinocyte function. Mechanism: VDR-mediated gene effects. PMC+1

---

Procedures / Surgeries

AEI usually does not require surgery. In selected situations, procedures can help symptoms or complications:

1. Office debridement of plantar keratoderma
   Periodic careful paring of thick soles to reduce pain and fissures. Why: improves walking comfort and prevents cracks. akademiska.se

2. Occlusive “heel fissure” taping / gluing techniques
   Clinical adhesives and taping help close painful cracks while the barrier heals. Why: reduces infection risk and pain. akademiska.se

3. Management of secondary nail problems (onychodystrophy)
   Debridement or partial procedures when thickened nail edges injure skin. Why: reduce trauma from sharp plates. akademiska.se

4. Ectropion correction (mainly in other ichthyoses; rare in AEI)
   If severe eyelid turning-out occurs (uncommon in AEI), oculoplastic surgery may be considered. Why: protect the cornea. akademiska.se

5. Biopsy for diagnosis (punch biopsy)
   A small diagnostic procedure confirms the hallmark “epidermolytic hyperkeratosis.” Why: secure diagnosis and guide care. DermNet®

---

Prevention Tips

1. Keep a daily soak-and-seal routine—consistency prevents flares. akademiska.se

2. Use fragrance-free, dye-free skin products to avoid irritation. akademiska.se

3. Avoid overheating; choose breathable clothes and manage sweat. PubMed

4. Protect hands and feet—soft socks, roomy shoes, and emollients before bed. akademiska.se

5. Trim nails to reduce scratching injury. akademiska.se

6. Humidify your room in dry seasons. akademiska.se

7. Treat infections early—watch for honey-colored crusts, warmth, swelling. akademiska.se

8. Follow clinician guidance on acids/keratolytics in infants and toddlers. HUSC

9. Plan bone/lab monitoring if on long-term oral retinoids. PMC

10. Seek genetic counseling for family planning questions. Orpha.net

---

When to see a doctor (or go now)

• Newborns/infants with widespread redness, blisters, feeding problems, or fever—urgent assessment is needed to ensure fluids, infection control, and safe topical choices. akademiska.se

• Any age with painful cracks, pus, spreading redness, fever, or rapidly worsening plaques—possible infection needs prompt antibiotics. akademiska.se

• If walking/hand function is limited by thick skin or fissures—consider procedural care and optimized therapy. akademiska.se

• If starting or using oral retinoids—you need baseline labs, pregnancy prevention planning (if applicable), and scheduled monitoring. PMC

• If vision irritation or eyelid turning-out is suspected—eye protection and specialist review are important. akademiska.se

---

What to eat and what to avoid

1. Balanced diet with adequate protein and essential fats to support skin building blocks. First Skin Foundation

2. Consider omega-3-rich foods (e.g., oily fish) after discussing with your clinician; evidence is general, not AEI-specific. PMC

3. Check vitamin D status; supplement only if low or as advised. PMC

4. Hydrate sensibly—regular water intake matched to thirst/activity. akademiska.se

5. Favor whole foods (fruits/vegetables/whole grains) over ultra-processed snacks to reduce inflammatory load. ScienceDirect

6. If you notice food-related flares, keep a diary and review with a clinician (true food triggers are uncommon but individual). Healthline

7. Avoid extreme or restrictive diets that risk nutrient gaps; they don’t cure AEI. ScienceDirect

8. Discuss plant-ceramide supplements (if interested) with your clinician; choose studied doses. PMC

9. Limit alcohol if on retinoids (liver/lipids). PMC

10. Maintain a healthy weight—less friction and sweating helps the skin. akademiska.se

---

Frequently Asked Questions

1. Is AEI contagious?
   No. It is a genetic condition—you can’t catch or spread it. GARD Information Center

2. Will my child outgrow it?
   Newborn blistering often improves, but the tendency for annular scaly plaques and thick palms/soles can persist and flare over time. PubMed

3. What causes the ring-shaped patches?
   Flares of fragile skin and rapid repair create moving, polycyclic scaly plaques typical of AEI. PMC

4. How is AEI different from “regular” epidermolytic ichthyosis?
   AEI is a clinical variant with recurrent annular plaques; both are linked to KRT1/KRT10 mutations and show epidermolytic hyperkeratosis on biopsy. DermNet®+1

5. Can creams cure AEI?
   No cure exists yet. Emollients and keratolytics manage symptoms; some people need oral retinoids for heavy scale. akademiska.se+1

6. Are acids like lactic or salicylic safe for babies?
   No—avoid these in young children; urea is limited in neonates. Always follow age-specific guidance. ResearchGate+1

7. Do retinoids thin the skin too much?
   At proper doses they reduce thick scale; side effects require monitoring (liver, lipids, bones) and pregnancy prevention plans. PMC

8. Is genetic testing helpful?
   Yes. It confirms the diagnosis (KRT1/KRT10) and informs family planning. DermNet®+1

9. What triggers flares?
   Heat, friction, infections, and inconsistent skin care are common triggers. PubMed

10. Can diet fix AEI?
    Diet can support skin health (e.g., vitamin D if low, essential fats), but it does not replace medical care. Evidence is limited in AEI. PMC+1

11. Are “immune boosters” or stem-cell treatments available?
    Not for AEI at this time; such approaches are experimental. SpringerLink

12. What about ceramide supplements?
    Small studies show improved hydration/barrier with oral plant ceramides; discuss dose/brand with your clinician. PMC+1

13. Can I exercise?
    Yes—manage heat/sweat with breathable clothes, cool-down, and moisturize after. akademiska.se

14. How often should I follow up?
    At least yearly for stable disease, sooner during medication changes or frequent flares; bone/lab checks if on retinoids. PMC

15. Will research bring a cure?
    Advances in genetic and barrier therapies are happening, but no cure yet; supportive care remains key. SpringerLink

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 19, 2025.